Trial intelligence / Profile preview

Procenta for Non-Healing Diabetic Foot and Ankle Ulcers

NCT05099887Unknown

Sponsor
VA Western New York Healthcare System
Start
Dec 2021
Primary completion
Mar 2022
Modality
Biologic, HPTA (Human placental tissue allograft)
01

Overview

Open-label, single-arm trial of Procenta in diabetic foot ulcer (DFU), sponsored by VA Western New York Healthcare System. Primary endpoint: Percent of Wound closure at 6 months. Status: unknown.

02

Drugs

Procenta
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT05099887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05099887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call